265 related articles for article (PubMed ID: 16443423)
1. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
Reuben DB; Palla SL; Hu P; Reboussin BA; Crandall C; Herrington DM; Barrett-Connor E; Greendale GA
Am J Med; 2006 Feb; 119(2):167.e1-8. PubMed ID: 16443423
[TBL] [Abstract][Full Text] [Related]
2. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
Lakoski SG; Herrington DM
Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
[TBL] [Abstract][Full Text] [Related]
4. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
[TBL] [Abstract][Full Text] [Related]
5. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
Heald A; Selby PL; White A; Gibson JM
Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
[TBL] [Abstract][Full Text] [Related]
7. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.
Crandall CJ; Karlamangla A; Huang MH; Ursin G; Guan M; Greendale GA
Arch Intern Med; 2006 Aug 14-28; 166(15):1578-84. PubMed ID: 16908790
[TBL] [Abstract][Full Text] [Related]
10. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
Kiran H; Kiran G
Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
[TBL] [Abstract][Full Text] [Related]
12. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
13. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
Hu P; Greendale GA; Palla SL; Reboussin BA; Herrington DM; Barrett-Connor E; Reuben DB
Atherosclerosis; 2006 Apr; 185(2):347-52. PubMed ID: 16023653
[TBL] [Abstract][Full Text] [Related]
14. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J
Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.
Lakoski SG; Brosnihan B; Herrington DM
Am Heart J; 2005 Nov; 150(5):907-11. PubMed ID: 16290959
[TBL] [Abstract][Full Text] [Related]
17. Effects of alcohol and cigarette smoking on change in serum estrone levels in postmenopausal women randomly assigned to fixed doses of conjugated equine estrogens with or without a progestin.
McDivit AM; Greendale GA; Stanczyk FZ; Huang MH
Menopause; 2008; 15(2):382-5. PubMed ID: 18000469
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
[TBL] [Abstract][Full Text] [Related]
19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
20. Estrogen, progestogens and cardiovascular risk.
Stefanick ML
J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]